Tricuspid Valve Regurgitation
25
8
12
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 25 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
63%
5 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (25)
2019-06 TRISCEND Study
The TRICURE EU Pivotal Study
The TRICURE EFS Study
VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
TRISCEND II Pivotal Trial
Prospective Study of Lead-associated Tricuspid Regurgitation in Patients Undergoing New Transvalvular Lead Insertion
Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
Clinical Study of the inQB8 TTVR System
An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Patients Treated with the Abbott TriClip™ Device (bRIGHT)
Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)
TRISCEND JAPAN Study
MATTERS Study - Mistral Percutaneous Tricuspid Valve Repair FIM Study
MATTERS II - Mistral Percutaneous Tricuspid Valve Repair FIM Study
Short Term Outcomes Of Tricuspid Valve Annuloplasty Using A Flexible Band
Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Miral Operation
Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System
Mistral Percutaneous Tricuspid Valve Durable Repair Pivotal Study
Structural Heart and Valve Network PROSPECTIVE Registry
The SPACER Trial - Repair of Tricuspid Valve Regurgitation Using the Edwards TricuSPid TrAnsCatheter REpaiR System
TriBEL Registry: National Belgian Registry of Percutaneous Tricuspid Valve Repair Using a Transcatheter Edge-to-edge Repair Technique